×
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.98 (+1.72%)
AAPL   141.54 (+1.88%)
MSFT   262.90 (+1.28%)
META   168.25 (+5.14%)
GOOGL   2,264.66 (+4.13%)
AMZN   113.36 (+3.47%)
TSLA   701.50 (+2.89%)
NVDA   149.83 (+3.17%)
NIO   22.15 (+3.70%)
BABA   120.29 (+3.70%)
AMD   75.12 (+1.97%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.10 (-0.99%)
GE   62.03 (-2.38%)
F   11.19 (-1.15%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.36 (+4.15%)
NFLX   185.64 (+3.16%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.98 (+1.72%)
AAPL   141.54 (+1.88%)
MSFT   262.90 (+1.28%)
META   168.25 (+5.14%)
GOOGL   2,264.66 (+4.13%)
AMZN   113.36 (+3.47%)
TSLA   701.50 (+2.89%)
NVDA   149.83 (+3.17%)
NIO   22.15 (+3.70%)
BABA   120.29 (+3.70%)
AMD   75.12 (+1.97%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.10 (-0.99%)
GE   62.03 (-2.38%)
F   11.19 (-1.15%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.36 (+4.15%)
NFLX   185.64 (+3.16%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.98 (+1.72%)
AAPL   141.54 (+1.88%)
MSFT   262.90 (+1.28%)
META   168.25 (+5.14%)
GOOGL   2,264.66 (+4.13%)
AMZN   113.36 (+3.47%)
TSLA   701.50 (+2.89%)
NVDA   149.83 (+3.17%)
NIO   22.15 (+3.70%)
BABA   120.29 (+3.70%)
AMD   75.12 (+1.97%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.10 (-0.99%)
GE   62.03 (-2.38%)
F   11.19 (-1.15%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.36 (+4.15%)
NFLX   185.64 (+3.16%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.98 (+1.72%)
AAPL   141.54 (+1.88%)
MSFT   262.90 (+1.28%)
META   168.25 (+5.14%)
GOOGL   2,264.66 (+4.13%)
AMZN   113.36 (+3.47%)
TSLA   701.50 (+2.89%)
NVDA   149.83 (+3.17%)
NIO   22.15 (+3.70%)
BABA   120.29 (+3.70%)
AMD   75.12 (+1.97%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.10 (-0.99%)
GE   62.03 (-2.38%)
F   11.19 (-1.15%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.36 (+4.15%)
NFLX   185.64 (+3.16%)
NASDAQ:CRNX

Crinetics Pharmaceuticals Insider Trading & Ownership

$19.88
+1.03 (+5.46%)
(As of 07/5/2022 03:59 PM ET)
Add
Compare
Today's Range
$18.73
$19.91
50-Day Range
$16.49
$21.27
52-Week Range
$15.91
$28.95
Volume
9,985 shs
Average Volume
346,880 shs
Market Capitalization
$1.06 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$41.00

Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$27.26 M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$7.94 M

CRNX Insider Buying and Selling by Quarter

Get CRNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Crinetics Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/2/2022Stephen F BetzInsiderSell3,247$20.10$65,264.70107,598  
4/18/2022Perceptive Advisors LlcMajor ShareholderBuy157,515$22.22$3,499,983.305,321,032  
4/18/2022Stephen F BetzInsiderSell5,664$25.81$146,187.84110,845  
4/13/2022Richard Scott StruthersCEOSell138,643$26.83$3,719,791.69730,805  
4/5/2022Richard Scott StruthersCEOSell21,357$25.34$541,186.3857,400  
4/4/2022Stephen F BetzInsiderSell9,000$23.97$215,730.00116,509  
3/31/2022Stephen F BetzInsiderSell4,164$21.06$87,693.84  
3/1/2022Stephen F BetzInsiderSell3,123$19.73$61,616.79  
2/7/2022Ajay MadanInsiderSell13,411$17.83$239,118.13  
2/1/2022Stephen F BetzInsiderSell3,123$18.79$58,681.17  
1/18/2022Stephen F BetzInsiderSell4,168$23.29$97,072.72  
1/3/2022Stephen F BetzInsiderSell7,168$28.02$200,847.36  
12/28/2021Stephen F BetzInsiderSell3,000$27.95$83,850.00  
12/15/2021Stephen F BetzInsiderSell5,668$24.14$136,825.52  
12/1/2021Stephen F BetzInsiderSell5,668$27.38$155,189.84  
11/8/2021Stephen F BetzInsiderSell3,900$28.42$110,838.00  
11/5/2021Stephen F BetzInsiderSell12,600$27.95$352,170.00  
11/1/2021Matthew K FustDirectorSell8,954$25.50$228,327.00  
11/1/2021Stephen F BetzInsiderSell5,668$24.79$140,509.72  
10/27/2021Stephen F BetzInsiderSell3,000$24.00$72,000.00  
10/25/2021Perceptive Advisors LlcMajor ShareholderBuy1,200,000$19.80$23,760,000.00  
10/21/2021Stephen F BetzInsiderSell1,042$21.10$21,986.20  
9/8/2021Matthew K FustDirectorSell6,046$25.50$154,173.0018,582  
9/7/2021Richard Scott StruthersCEOSell30,000$25.00$750,000.00  
7/26/2021Matthew K FustDirectorSell5,000$19.59$97,950.00  
7/19/2021Matthew K FustDirectorSell5,000$19.50$97,500.0017,536  
7/12/2021Matthew K FustDirectorSell5,000$20.71$103,550.00  
4/8/2021Perceptive Advisors LlcMajor ShareholderBuy304,136$16.44$4,999,995.84  
12/2/2020Richard Scott StruthersCEOBuy1,000$12.60$12,600.004,000  
7/15/2020Richard Scott StruthersCEOSell17,500$15.30$267,750.00  
4/17/2020Vivo Capital Viii, LlcMajor ShareholderSell84,598$15.40$1,302,809.20  
4/15/2020Vivo Capital Viii, LlcMajor ShareholderSell215,810$15.50$3,345,055.00  
4/7/2020Vivo Capital Viii, LlcMajor ShareholderSell6,115$14.20$86,833.00  
4/3/2020Vivo Capital Viii, LlcMajor ShareholderSell300,000$13.80$4,140,000.00  
3/9/2020Vivo Capital Viii, LlcMajor ShareholderSell528$19.50$10,296.00  
2/10/2020Vivo Capital Viii, LlcMajor ShareholderSell7,555$21.40$161,677.00  
2/7/2020Vivo Capital Viii, LlcMajor ShareholderSell5,905$22.00$129,910.00  
2/4/2020Vivo Capital Viii, LlcMajor ShareholderSell13,460$22.80$306,888.00  
1/31/2020Vivo Capital Viii, LlcMajor ShareholderSell5,400$21.70$117,180.00  
1/29/2020Vivo Capital Viii, LlcMajor ShareholderSell13,920$22.20$309,024.00  
12/16/2019Matthew K FustDirectorSell3,500$22.50$78,750.0016,036  
6/21/2019Ventures Iv L.P. 5AmInsiderSell250,000$22.20$5,550,000.00  
3/20/2019Vivo Capital Fund Viii, L.P.Major ShareholderSell417,000$22.25$9,278,250.00  
3/18/2019Ventures Iv L.P. 5AmMajor ShareholderSell154,839$24.25$3,754,845.75  
1/22/2019Ventures Iv L.P. 5AmMajor ShareholderSell262,153$21.88$5,735,907.64  
7/20/2018Alan Seth KrasnerInsiderBuy2,000$17.00$34,000.00  
7/20/2018Life Sciences Maste PerceptiveDirectorBuy400,000$17.00$6,800,000.00  
7/20/2018Vivo Capital Viii, LlcMajor ShareholderBuy353,180$18.62$6,576,211.60  
(Data available from 1/1/2013 forward)












Crinetics Pharmaceuticals Insider Trading - Frequently Asked Questions

Who is on Crinetics Pharmaceuticals's Insider Roster?

The list of insiders at Crinetics Pharmaceuticals includes Ajay Madan, Matthew K Fust, Perceptive Advisors Llc, Richard Scott Struthers, Stephen F Betz, and Vivo Capital Viii, Llc. Learn more on insiders at CRNX.

What percentage of Crinetics Pharmaceuticals stock is owned by insiders?

5.90% of Crinetics Pharmaceuticals stock is owned by insiders. Learn more on CRNX's insider holdings.

Which Crinetics Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased Crinetics Pharmaceuticals stock in the last 24 months: Perceptive Advisors Llc ($32,259,979.14), and Richard Scott Struthers ($12,600.00).

How much insider buying is happening at Crinetics Pharmaceuticals?

Insiders have purchased a total of 1,662,651 Crinetics Pharmaceuticals shares in the last 24 months for a total of $32,272,579.14 bought.

Which Crinetics Pharmaceuticals insiders have been selling company stock?

The following insiders have sold Crinetics Pharmaceuticals stock in the last 24 months: Ajay Madan ($239,118.13), Matthew K Fust ($681,500.00), Richard Scott Struthers ($5,278,728.07), and Stephen F Betz ($2,006,463.70).

How much insider selling is happening at Crinetics Pharmaceuticals?

Insiders have sold a total of 331,114 Crinetics Pharmaceuticals shares in the last 24 months for a total of $8,205,809.90 sold.

This page (NASDAQ:CRNX) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.